Biography

Professor David Strain is a clinician-researcher at the University of Exeter Medical School and an honorary consultant in medicine for older people. His clinical and academic work spans cardiometabolic health, diabetes, vascular medicine, frailty, stroke and long COVID.

As Chair of the British Medical Association’s Board of Science and Parliament’s Thematic Research Lead for Health for 2024–26, David works at the interface of clinical practice, scientific evidence and national health policy.

David has developed and lectured internationally as a prominent clinical and policy voice on artificial intelligence in healthcare. He led the BMA’s major review of AI use across the healthcare system, examining its current and future applications, potential benefits and risks, and establishing principles for its safe, effective, ethical and equitable adoption. His work emphasises robust real-world clinical validation, ongoing monitoring, transparency, clinician accountability, patient choice, inclusive development and protection of the doctor–patient relationship.

He has also written and contributed to BMA blogs and commentary exploring AI governance, private technology platforms, NHS data sovereignty and control of the knowledge generated from patient data. His wider publications include BMJ commentary examining whether AI can help deliver meaningful reform across the NHS.

Biography

Dr Tahreema Matin is an award-winning medical leader and Consultant Radiologist with extensive experience spanning the NHS, academia, government and industry. As Associate Medical Director at NHS England, she leads national work across workforce, education and digital transformation, including chairing the AI and Digital Working Group for the Medical Education and Training Review. She is also Medical Director at Prenuvo, where she successfully led the launch of its London flagship clinic and is now supporting expansion into other international markets. She is a Trustee of Picker Institute Europe, reflecting her commitment to keeping patients at the heart of healthcare transformation. Her work focuses on harnessing AI and innovation to advance preventive healthcare and early detection, and translating these advances into safe, scalable and equitable patient care.

Biography

Mike Hill is the Atos UK&I Head of Technology responsible for the capabilities, services, resources and solutions across the UK&I business lines; spanning Cyber, Modern Infrastructure, Data & AI, Digital Workplace and Digital Applications.

Prior to joining Atos in May 2025, Mike held several senior CDIO and CIO roles, including CDIO at RICS, CDIO at the Cabinet Office and CIO for the Home Office Police & Public Protection Technology organisation. He is a people-centric technology leader focused on innovation, transformation and organisational development. Mike holds an MBA, is a graduate of the Civil Service Major Projects Leadership Academy (MPLA) and is a Fellow of the British Computer Society (FBCS).

Biography

Neil Vaughan is Associate Professor of Data Science and AI at University of Exeter. His research is developing medical technology and AI for healthcare. His research includes AI, data science and health technology including Virtual Reality (VR), medical training simulators and haptic feedback. His research developed a patented smartphone neuropathy diagnosis Point of care testing (POCT) device. His research received Innovation awards form IET, ASME and NHS. He was awarded a Royal Academy of Engineering (RAEng) Research Fellowship focussed on AI in healthcare. He has organised AI health technology conference workshops and edited journal special issues on AI healthcare.

Biography

Dr David Montgomery is co-founder of PM Life Sciences Consulting and a pharmaceutical physician with senior leadership experience across biotechnology, pharmaceuticals, healthtech, charity and policy. David spent the bulk of his industry career at Pfizer with increasingly senior medical roles including periods as UK medical director as VP head of scientific exchange, responsible for global oncology medical communications. He has also served as UK Medical Director at Ipsen, Menarini Stemline and Daiichi Sankyo, and as Executive Director of Research at Prostate Cancer UK. He advises and invests in healthtech, has served as a Non-Executive Director, and has held industry and public-interest roles including representing industry during the setting up of the Cancer Drugs Fund, on which he also served as a voting panellist and as a full voting member on the Scottish Medicines Consortium Committee. He is Responsible Officer for Revalidation at the Faculty of Pharmaceutical Medicine and represents the Faculty on the BMA Medical Academic Staff Committee.

Biography

Nicholas S Peters is Professor of Cardiology and Consultant Cardiologist at Imperial College & NHS Trust. He directs Imperial’s Health Impact Lab https://healthimpactlab.co.uk/ responsible for the largest deployment of AI in frontline primary care in the NHS and worldwide, combining system-wide clinical leadership and a blueprinted implementation framework. Successful large-scale deployments have been repeated across several clinical populations, and include earlier diagnostic, prevention and treatment pathways all impacting patients and delivery of the NHS long-term plan.

With a relentless focus on the "moonshot" of delivering new pathways direct to care, the Health Impact Lab addresses workforce, governance, regulatory, clinical, population and behavioural factors required for clinical and economic benefit with patient approval, and now being extended nationwide.

Professor Peters has held clinical-lead, executive and non-executive positions in UK and US health, commercial and academic boards, has >350 publications – most recently in remote and connected care, deployment of AI, clinical and consumer devices in the world’s highest impact clinical journals

Biography

Phil McEwen is founder and CEO of Health Economics and Outcomes Research Ltd, a Cardiff-based consultancy specialising in health economics, market access and evidence generation. A mathematician by training, his PhD at Cardiff University in the 1990s used artificial neural networks to estimate the hidden number of people infected with HIV, an early application of machine learning applied to an ill-posed inverse problem in public health.

Over more than 20 years since, he has built models that help health systems decide which treatments to fund. He developed the Cardiff Diabetes Model and its successor, the Cardiff Cardio-Kidney-Metabolic Model, has published more than 450 papers, co-authored the ISPOR-SMDM Modelling Good Research Practices report on model conceptualisation, and sits on the Mount Hood Diabetes Challenge Network organising committee. His team's machine learning work includes developing risk equations using UK primary care data (CPRD) and dynamic population-based disease models to inform public health.

At HEOR, Phil is leading how the firm adopts AI across modelling, evidence synthesis and writing, guided by two tests: does it make the work more accurate and useful, and does it make the people doing it better researchers?

Biography

Dr Kishan Rees is a physician, educator, broadcaster and systems builder with a twenty-year career spent closing the gap between what is known and what people are able to know. He leads global video and digital media strategy at Bayer, directing digital patient and scientific engagement across cardiovascular, renal, oncology and women's health. Named the PM Society's Pharma Marketing Pioneer 2025, he has delivered user-generated content strategies globally in a highly regulated industry, and led media capability for the Bayer-funded Heart & Kidney Care Alliance, a collective of 22 patient organisations globally. Having completed core surgical training, he then navigated emergency medicine, NHS innovation and broadcast media as a Sky News health contributor. His MD research on medical communication during COVID-19 gives academic rigour to his content work.

Biography

Professor Hatim Abdulhussein is the CEO for Health Innovation Kent Surrey Sussex and continues to practice as a General Practitioner. He advocates for responsible AI transformation and ensuring workforce preparedness for new technologies in health and care. He co-founded the ‘Topol Programme for Digital Health Fellowships’ launched by the Secretary of State for Health and Social Care in 2019 and later became the National Clinical Lead for AI and Digital Workforce at NHS England, providing leadership to the NHS Digital Academy and the NHS AI Lab and co-authoring on AI in the NHS’s Long Term Workforce Plan for the NHS.